Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reversible alterations of brain acetate metabolism associated with alcohol consumption.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

An opioid-withholding human laboratory paradigm during opioid agonist treatment for opioid use disorder and chronic pain: Phase- and dose-dependent effects of cannabidiol.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Lower synaptic density in mood circuitry underlies depression in Parkinson's disease.

Brain communications·2026
Same author

Synaptic density imaging in behavioral variant frontotemporal dementia: A comparison of <sup>1</sup> <sup>8</sup>F-SynVesT-1 and <sup>1</sup> <sup>8</sup>F-FDG PET.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Naltrexone/bupropion for binge-eating disorder: A human laboratory investigation of mechanisms.

Drug and alcohol dependence reports·2026
Same author

Additional analyses do not implicate opioid signaling in the antidepressant effects of ketamine.

The international journal of neuropsychopharmacology·2026

Related Experiment Video

Updated: May 20, 2026

Localization of Plasma Membrane and Intracellular Neuronal Nicotinic Acetylcholine Receptors Using Quantitative Imaging in Mammalian Cells
09:06

Localization of Plasma Membrane and Intracellular Neuronal Nicotinic Acetylcholine Receptors Using Quantitative Imaging in Mammalian Cells

Published on: December 19, 2025

Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder.

Aybala Saricicek1, Irina Esterlis, Kathleen H Maloney

  • 1Department of Psychiatry, Yale University, New Haven, CT, USA. aybala.saricicek@yahoo.com

The American Journal of Psychiatry
|July 10, 2012
PubMed
Summary

Major depressive disorder is linked to lower availability of beta-2 subunit-containing nicotinic acetylcholine receptors (β2*-nAChRs). This reduction was observed in vivo using SPECT imaging but not in postmortem brain samples.

More Related Videos

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Related Experiment Videos

Last Updated: May 20, 2026

Localization of Plasma Membrane and Intracellular Neuronal Nicotinic Acetylcholine Receptors Using Quantitative Imaging in Mammalian Cells
09:06

Localization of Plasma Membrane and Intracellular Neuronal Nicotinic Acetylcholine Receptors Using Quantitative Imaging in Mammalian Cells

Published on: December 19, 2025

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

  • Neuroscience
  • Psychiatry
  • Molecular Biology

Background:

  • Nicotinic acetylcholine receptors (nAChRs) modulation, particularly those with the beta-2 subunit (β2*), shows potential for treating major depressive disorder.
  • Previous research suggests a link between nAChRs and depression, necessitating further investigation into receptor availability.

Purpose of the Study:

  • To investigate the availability of β2*-nAChRs in patients with major depressive disorder using [123I]5-I-A-85380 SPECT imaging.
  • To explore the molecular basis of altered β2*-nAChR binding in depressed individuals through postmortem brain sample analysis.

Main Methods:

  • In vivo study involved 23 medication-free depressed subjects and 23 controls undergoing [123I]5-I-A-85380 SPECT and MRI scans.
  • Postmortem analysis examined β2*-nAChR binding using [123I]5-I-A-85380 on prefrontal cortex samples from 14 depressed subjects and 14 controls.

Main Results:

  • Significantly lower β2*-nAChR availability was found in both acutely ill and recovered depressed subjects compared to controls across all brain regions.
  • Acutely ill depressed subjects exhibited lower β2*-nAChR availability than recovered subjects.
  • In depressed patients, β2*-nAChR availability correlated with the number of depressive episodes, trauma, and anxiety scores.

Conclusions:

  • Depressed patients demonstrate reduced in vivo β2*-nAChR availability compared to healthy individuals.
  • The discrepancy between in vivo and postmortem findings may relate to endogenous acetylcholine levels, similar to observations with dopaminergic ligands.